British researchers have identified two common genetic mutations that increase the risk of osteoporosis and related bone fractures, according to a study.
The Lancet medical journal.
Bone mass increasing drugs could cut fracture risk too
Drugs called bisphosphonates are used primarily to increase bone mass and cut the risk of fractures in patients with osteoporosis.
Lancet study, the team scanned the genes of 2 094 female twins and identified a link between decreased bone mineral density and changes in chromosomes 8 and 11.
What the findings mean
The findings are an important step forward toward better understanding of the genetic basis of osteoporosis, other researchers wrote in a Lancet commentary.